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C E N T R E D ' E T U D E S E T D E R E C H E R C H E S S U R L E D E V E L O P P E M E N T I N T E R N A T I O N

INTRODUCTION
Smear microscopy has a low sensitivity (50%) compared to the Mycobacterium tuberculosis (MTB) culture reference standard 8 . This sensitivity is even more reduced in HIV infected patient [9] [10] [11] . In 2007, the WHO reviewed its diagnostic algorithms for smear-negative patients and recommended, when available, MTB culture and an earlier and systematic chest X-ray examination 12 . However, culture requires high infrastructure level, highly qualified staff and scrupulous respect of safety standards 12 .
Due to the very low access to the MTB cultures in resource-limited settings, smear-negative TB suspected patient are diagnosed on the basis of clinical examination, chest X-ray and absence of response to an antibiotic trial targeting bacterial pneumonias 13 . The performances of these diagnostic algorithms are disappointing, leading to a sub-diagnosis of true TB cases and overtreatment of non-TB cases 14 .
The MGIT liquid culture method is the most sensitive culture but remains expensive and has an increased safety risk compared to methods using solid media 14 . There are non-commercial alternatives, such as Thin Layer Agar culture (TLA) 15 , based on the microscopic observation of MTB on agar medium. Sensitivity is close to the Löwenstein-Jensen (LJ) classical method, but faster (10-15days against 30-40 days for LJ) [16] [17] [18] [19] . To improve the TB diagnosis in the Homa Bay District, MSF introduced the TLA and LJ cultures in the laboratory of the district hospital 20 .
This study aims to address the question whether the introduction of the rapid non-commercial TLA culture together with LJ culture increased the number of true TB patients started on treatment among smear-negative pulmonary TB suspects and for which cost. 
METHODS
Diagnostic algorithms
The conventional diagnostic algorithm based on clinical, radiological features and use of an antibiotic trial is compared with the culture-based algorithm which includes the TLA and LJ cultures in addition to the conventional algorithm (Figures 1 and 2 ). The diagnostic algorithm included several steps after which some patients could be started on TB treatment.
In the conventional algorithm, when the chest X-ray and/or clinical examination were suggestive of TB, patients were started on TB treatment (A block). Otherwise, they received an antibiotic trial (amoxicilline 1g 3x/j) for five days followed by a second clinical examination and sputum microscopy examination. The decision to start or not a TB treatment was decided by the clinician (B block) who could prescribe a second antibiotic treatment and perform a third clinical examination (C block). from the hospital, having at least a cough of two weeks and with two negative smears. Two sputa per patient were collected for TLA and LJ cultures. Due to the delay of the TLA culture results, the effectiveness criterion was independently assessed in the same patients without taking into account the therapeutic decision based on the culture result for conventional algorithm and using culture results for the culture-based algorithm (Figures 1 and 2 ).
Costs estimation
The collection of data (Appendix Table A The staff (clinician, nurse, lab technician) cost was calculated by either multiplying the time spent in the activity by the cost of a unit (minute) of work time or from the average number of patients per day.
The work time of the laboratory technicians in charge of the culture was not easily observable hence we adopted the productivity approach 22 . In 2009, 1195 cultures were carried out at the laboratory, equivalent to an average of two tested patients per day (with 2 samples per patient) for each of the three laboratory technicians. The unit cost of supervisor work of and maintenance worker was The materiel and furniture cost includes the cost of treatment, X-Ray, and laboratory equipment. The cost of the first (0.87€) and second (4.4€) antibiotics treatment and TB treatment (22€ for 6 months rifampicin based regimen) was based on a lump sum estimated by MSF. The cost of chest X-ray was based on a lump sum of 1.84€ per X-ray. The cost of small equipment and furniture for microscopy (0.442€ per blade) was based on a previous study in Kenya 23 . For the culture, the equipment and supplies cost included all medical consumables (autoclave pipette, bunsen …), non-medical (gas lighter, lamp, sink, strainer …) and reagents expenditures.
For the running cost, the culture laboratory shared the waste water treatment and waste management with the hospital. We allocated 4.06% of this cost to the culture laboratory, using the surface area as allocation key. The investment cost included medical and non-medical equipment cost and the depreciation of the vehicle used (Table A1 ). For joint fixed costs, the allocation key was the activity for the TB diagnosis linking to the hospital activity. They were allocated into three services, 10.5% for microscopy, 59.5% for laboratory equipment or the culture laboratory and 30% for the general laboratory. Based on the nomenclature used by the city of Lyon, 24 the lifetime for depreciation estimation is 10 years for laboratory equipment, 15 years for air-conditioning, seven years for fridges, 25 years for buildings and three years for motorcycles.
The total cost was estimated by adding the cost of all different categories listed above according to their use in the conventional and culture-based algorithms, respectively (Table 1) .
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Economic Evaluation
The efficiency of TLA/LJ culture was estimated by calculating the incremental cost-effectiveness ratio (ICER) for the conventional and culture-based diagnostic algorithms (Cost (cult) -Cost / (result (cult) -result) 25 . The effectiveness outcome was the number of true TB cases (positive culture) starting on treatment. There were 33 patients when using the conventional algorithm compared to 60 patients when using the culture-based algorithm. Univariate sensitivity analysis was performed on the number of TB suspects (1680, as the total number of patients screened at the Homa-Bay laboratory in 2009) and on the proportion of true TB cased identified by the culture-based algorithm who were started on treatment after been traced. In study condition, the proportion was 100% whereas it was close to 75% in programmatic condition 7 . We used a tracing coverage rate of 75% and 50% for the sensitivity analysis.
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RESULTS
A total of 380 smear-negative pulmonary TB patients were included in the study 7 . Following the first clinical examination and chest radiography, 66 patients were treated for TB and 314 received an antibiotic trial. Among the last ones, 57 were started on TB treatment based on clinical and microscopy results, 232 were not considered as TB and withdrawn and 24 patients received a 2 nd antibiotic trial (Figure 1 ). In total, 25 patients were secondarily started on treatment after been traced due to a positive culture result (Figure 2 and Figure 3 ). 
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The costs detail is presented in Tables A1 to A3 in the Appendix. The overall cost of the care of the 380 smear-negative TB suspects was 15,026€ and 54,931€ with the conventional and culture-based algorithms, respectively. In the conventional algorithm, the main costs were human resources' cost (72%), followed by the anti-TB drugs cost (18.2%). The chest radiography represented only 4.6% of the total cost. With the culture-based algorithm, the human resources' cost represented only 39.4% of the overall cost, while the cost of materials and supplies participated for almost half of the cost (42.8%). The average cost per screened TB suspect was 39.5€ and 144.5€ for the conventional and culture-based algorithms, respectively. The cost per true TB case started on treatment was 455.3€ when using the conventional algorithm compared to 915.5€ when using the culture-based algorithm ( Table 2) . As shown by the ICER, the culture allowed starting TB treatment in 27 additional true TB cases for a total additional cost of 39,905€, equivalent of 1,478€ per new true TB case started on treatment (Table 3) . Using 75% and 50% of proportion of culture positive patients effectively started on treatment after tracing, the average cost per screened patient was 141.3€ and 138.1€, respectively euros. The ICER
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indicates that the cost per new true TB case started on TB treatment was 2036€ for a tracing coverage of 75% and 3122.7€ for a tracing coverage of 50% (Table 3 ).
When the number of patients is increased to 1680, the average cost per screened patient using the conventional algorithm was 39.5€ (Table A2) . Using the culture-based algorithm with a tracing coverage of 100%, 75% and 50%, the average cost per screened patient was 119.5€, 116.5€ and 109.4€, respectively (Tables 2 and A3 ). The ICER per new true TB case started on treatment was 1129.6€, 1541€ and 2217.5€ with the respective tracing coverage of 100%, 75% and 50% (Table 3) . 
DISCUSSION
The cost analysis was considered from the district hospital perspective and does not include the cost for the patient. The culture-based algorithm was more expensive than the conventional algorithm.
Indeed, it requires expensive equipment and many supplies whereas the conventional algorithm without culture depends mainly on human resources. The use of thresholds in decision-making has met some criticism, such as, among others, the risk of uncontrolled growth in health-care expenditure.
However, thresholds represent the societal willingness-to-pay for health-care, and for that, this decision rule is considered more appropriate for societal decision-makers 26 . Moreover, budget impact analysis can complement cost-effectiveness analysis. The WHO 27 , considers cost-effective a strategy, which the cost-effectiveness ratio is less than three times the GDP per inhabitant of the country where the strategy is implemented.
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Despite a higher global cost, the culture-based algorithm was cost-effective. The cost per true TB case started on treatment (915.5€) was less than three times the GDP per capita of Kenya (1668€ in 2009) 28 .
The sensitivity analysis showed that the cost-effectiveness of the culture algorithm improved (757.7€) if we multiply, given the available resources of the studied laboratory, by four the number of screened patients. When the tracing coverage rate drops to 50%, the culture-based algorithm remained costeffective (924.2€, by true TB case started on treatment) regardless of the total number of screened patients. The additional cost per true TB case started on treatment with a tracing rate of 100% is not excessive (1478€) compared to the average cost (915€). It remains true when the tracing rate decreases to 75%.
The total cost for the diagnosis of presumed smear-negative TB increased from 15,026€ ( Cost-effectiveness studies about algorithm with culture in limited resources countries are relatively scarce 15 and we do not know any of the TLA culture. In addition, the comparison is difficult, the effectiveness outcome being not always the same 29 . Mueller et al. in a study on Zambia found a cost per detected case of 134€ with the MGIT culture and 231€ with the LJ culture 30 . When they focused on the smear negative TB suspects, the cost was 413€ with MGIT.
In this study, the culture contributed to put under treatment 27 patients who had escaped the clinical and radiological diagnosis who represented 42% of all TB confirmed patients. However, it requires an effective tracing of patients with a positive culture. Also, the long delays of culture results limit the impact of culture on the therapeutic decision. Therefore, the use of culture does not allow to reduce the potentially proportion of patients wrongly started on treatment based on clinical and radiological findings. A test with a similar sensitivity to the culture, but much faster would have more impact on the treatment decision, and would be probably more cost effective. Among the currently available tests, the XpertMTB/RIF assay is the one that comes closest to this ideal test with a sensitivity of 70% in smear-negative TB suspects compared with culture and results available in 2h 31 . This test has also the advantage of requiring infrastructure and expertises that are close the ones required by microscopy 32 . 
